Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: Colocalization with GABAergic and glutamatergic markers

Journal of Comparative Neurology

Volumn 520, Issue 5, 2012, Pages 1005-1020

  Hrabovszky, Erik ^a   Wittmann, Gábor ^a,b   Kalló, Imre ^a,c   Füzesi, Tamás ^a   Fekete, Csaba ^a,b   Liposits, Zsolt ^a,c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b TUFTS MEDICAL CENTER   (United States)

^c PÁZMÁNY PÉTER CATHOLIC UNIVERSITY   (Hungary)

Author keywords

aminobutyric acid (GABA); Endocannabinoid; Glutamic acid decarboxylase (GAD); In situ hybridization; Type 1 cannabinoid receptor (CB1); Vesicular glutamate transporter 2 (VGLUT2)

Indexed keywords

4 AMINOBUTYRIC ACID; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GLUTAMATE DECARBOXYLASE 65; GLUTAMIC ACID; MESSENGER RNA; VESICULAR GLUTAMATE TRANSPORTER 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; GABAERGIC SYSTEM; GENE EXPRESSION; GLUTAMATERGIC SYSTEM; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN SITU HYBRIDIZATION; LATERAL MAMMILLARY NUCLEUS; MALE; MOUSE; NERVE CELL; NERVOUS SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PHENOTYPE; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; TARGET CELL; THALAMUS LATERAL NUCLEUS; VENTRAL PREMAMMILLARY NUCLEUS;

ANIMALS; BIOLOGICAL MARKERS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HYPOTHALAMUS; MALE; MICE; NEURAL PATHWAYS; NEURONS; RECEPTOR, CANNABINOID, CB1; SEPTUM OF BRAIN;

EID: 84855964612     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22766     Document Type: Article

References (63)

1. Balagura S, Devenport LD. 1970. Feeding patterns of normal and ventromedial hypothalamic lesioned male and female rats. J Comp Physiol Psychol 71: 357-364.
2. Bellinger LL, Bernardis LL, Mendel VE. 1976. Effect of ventromedial and dorsomedial hypothalamic lesions on circadian corticosterone rhythms. Neuroendocrinology 22: 216-225.
3. Bellocchio L, Lafenetre P, Cannich A, Cota D, Puente N, Grandes P, Chaouloff F, Piazza PV, Marsicano G. 2010. Bimodal control of stimulated food intake by the endocannabinoid system. Nat Neurosci 13: 281-283.
4. Bernardis LL. 1973. Disruption of diurnal feeding and weight gain cycles in weanling rats by ventromedial and dorsomedial hypothalamic lesions. Physiol Behav 10: 855-861.
5. Blache D, Fabre-Nys CJ, Venier G. 1991. Ventromedial hypothalamus as a target for oestradiol action on proceptivity, receptivity and luteinizing hormone surge of the ewe. Brain Res 546: 241-249.
6. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF. 2005. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25: 6845-6856.
7. Borhegyi Z, Varga V, Szilagyi N, Fabo D, Freund TF. 2004. Phase segregation of medial septal GABAergic neurons during hippocampal theta activity. J Neurosci 24: 8470-8479.
8. Brooks CM, Lockwood RA, Wiggins ML. 1946. A study of the effect of hypothalamic lesions on the eating habits of the albino rat. Am J Physiol 147: 735-741.
9. Canteras NS, Simerly RB, Swanson LW. 1994. Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol 348: 41-79.
10. Chateau D, Kauffmann MT, Aron C. 1984. Are the amygdaloid projections to the hypothalamic ventromedial nucleus involved in estrous rhythm regulation in the female rat? Exp Clin Endocrinol 83: 303-309.
11. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thone-Reineke C, Ortmann S, Tomassoni F, Cervino C, Nisoli E, Linthorst AC, Pasquali R, Lutz B, Stalla GK, Pagotto U. 2003. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112: 423-431.
12. Degroot A, Kofalvi A, Wade MR, Davis RJ, Rodrigues RJ, Rebola N, Cunha RA, Nomikos GG. 2006. CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action. Mol Pharmacol 70: 1236-1245.
13. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
14. Donato J Jr, Silva RJ, Sita LV, Lee S, Lee C, Lacchini S, Bittencourt JC, Franci CR, Canteras NS, Elias CF. 2009. The ventral premammillary nucleus links fasting-induced changes in leptin levels and coordinated luteinizing hormone secretion. J Neurosci 29: 5240-5250.
15. Farkas I, Kalló I, Deli L, Vida B, Hrabovszky E, Fekete C, Moenter S, Watanabe M, Liposits Z. 2010. Retrograde endocannabionid signaling reduces GABA-ergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology 151: 5818-5829.
16. Freund TF, Antal M. 1988. GABA-containing neurons in the septum control inhibitory interneurons in the hippocampus. Nature 336: 170-173.
17. Fuchs SA, Edinger HM, Siegel A. 1985a. The organization of the hypothalamic pathways mediating affective defense behavior in the cat. Brain Res 330: 77-92.
18. Fuchs SA, Edinger HM, Siegel A. 1985b. The role of the anterior hypothalamus in affective defense behavior elicited from the ventromedial hypothalamus of the cat. Brain Res 330: 93-107.
19. Fukudome Y, Ohno-Shosaku T, Matsui M, Omori Y, Fukaya M, Tsubokawa H, Taketo MM, Watanabe M, Manabe T, Kano M. 2004. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur Journal Neurosci 19: 2682-2692.
20. Gerdeman G, Lovinger DM. 2001. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 85: 468-471.
21. Gifford AN, Ashby CR Jr. 1996. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J Pharmacol Exp Ther 277: 1431-1436.
22. Hayakawa T, Zyo K. 1989. Retrograde double-labeling study of the mammillothalamic and the mammillotegmental projections in the rat. J Comp Neurol 284: 1-11.
23. Herbison AE. 2008. Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: the case for the rostral periventricular area of the third ventricle (RP3V). Brain Res Rev 57: 277-287.
24. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1990. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87: 1932-1936.
25. Hoffman AF, Lupica CR. 2000. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci 20: 2470-2479.
26. Hrabovszky E, Liposits Z. 2008. Novel aspects of glutamatergic signalling in the neuroendocrine system. J Neuroendocrinol 20: 743-751.
27. Hrabovszky E, Petersen SL. 2002. Increased concentrations of radioisotopically-labeled complementary ribonucleic acid probe, dextran sulfate, and dithiothreitol in the hybridization buffer can improve results of in situ hybridization histochemistry. J Histochem Cytochem 50: 1389-1400.
28. Hrabovszky E, Vrontakis ME, Petersen SL. 1995. Triple-labeling method combining immunocytochemistry and in situ hybridization histochemistry: demonstration of overlap between Fos-immunoreactive and galanin mRNA-expressing subpopulations of luteinizing hormone-releasing hormone neurons in female rats. J Histochem Cytochem 43: 363-370.
29. Hrabovszky E, Kallo I, Steinhauser A, Merchenthaler I, Coen CW, Liposits Z. 2004. Estrogen receptor-beta in oxytocin and vasopressin neurons of the rat and human hypothalamus. Immunocytochemical and in situ hybridization studies. J Comp Neurol 473: 315-333.
30. Hrabovszky E, Halasz J, Meelis W, Kruk MR, Liposits Z, Haller J. 2005. Neurochemical characterization of hypothalamic neurons involved in attack behavior: glutamatergic dominance and co-expression of thyrotropin-releasing hormone in a subset of glutamatergic neurons. Neuroscience 133: 657-666.
31. Hrabovszky E, Csapo AK, Kallo I, Wilheim T, Turi GF, Liposits Z. 2006. Localization and osmotic regulation of vesicular glutamate transporter-2 in magnocellular neurons of the rat hypothalamus. Neurochem Int 48: 753-761.
32. Huang CC, Lo SW, Hsu KS. 2001. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J Physiol 532: 731-748.
33. Kato M, Suzuki M, Kakegawa T. 1983. Modification by hypothalamic lesions of the release of growth hormone (GH) following stimulation of the ventromedial hypothalamic nucleus in the rat. Brain Res 280: 69-74.
34. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558.
35. Katona I, Rancz EA, Acsady L, Ledent C, Mackie K, Hajos N, Freund TF. 2001. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 21: 9506-9518.
36. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
37. Krieger MS, Conrad LC, Pfaff DW. 1979. An autoradiographic study of the efferent connections of the ventromedial nucleus of the hypothalamus. J Comp Neurol 183: 785-815.
38. Marsicano G, Lutz B. 1999. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11: 4213-4225.
39. Matsuda LA, Bonner TI, Lolait SJ. 1993. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550.
40. McDonald AJ, Mascagni F. 2001. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 107: 641-652.
41. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90.
42. Millhouse OE. 1973. The organization of the ventromedial hypothalamic nucleus. Brain Res 55: 71-87.
43. Minano FJ, Myers RD. 1991. Anorexia and adipsia: dissociation from fever after MIP-1 injection in ventromedial hypothalamus and preoptic area of rats. Brain Res Bull 27: 273-278.
44. Nishizuka M, Pfaff DW. 1989. Intrinsic synapses in the ventromedial nucleus of the hypothalamus: an ultrastructural study. J Comp Neurol 286: 260-268.
45. Nyiri G, Szabadits E, Cserep C, Mackie K, Shigemoto R, Freund TF. 2005. GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons. Eur J Neurosci 21: 3034-3042.
46. Okada K, Wakabayashi I, Sugihara H, Minami S, Kitamura T, Yamada J. 1991. Electrical stimulation of hypothalamic periventricular nucleus is followed by a large rebound secretion of growth hormone in unanesthetized rats. Neuroendocrinology 53: 306-312.
47. Ottem EN, Godwin JG, Krishnan S, Petersen SL. 2004. Dual-phenotype GABA/glutamate neurons in adult preoptic area: sexual dimorphism and function. J Neurosci 24: 8097-8105.
48. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. 2006. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73-100.
49. Pan JT, Gala RR. 1985. Central nervous system regions involved in the estrogen-induced afternoon prolactin surge. II. Implantation studies. Endocrinology 117: 388-395.
50. Pang KC, Jiao X, Sinha S, Beck KD, Servatius RJ. 2011. Damage of GABAergic neurons in the medial septum impairs spatial working memory and extinction of active avoidance: effects on proactive interference. Hippocampus 21: 835-846.
51. Perkins MN, Rothwell NJ, Stock MJ, Stone TW. 1981. Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature 289: 401-402.
52. Piomelli D. 2003. The molecular logic of endocannabinoid signalling. Nat Rev 4: 873-884.
53. Richard D, Guesdon B, Timofeeva E. 2009. The brain endocannabinoid system in the regulation of energy balance. Best Pract Res Clin Endocrinol Metab 23: 17-32.
54. Rondini TA, Donato J, Jr., Rodrigues Bde C, Bittencourt JC, Elias CF. 2010. Chemical identity and connections of medial preoptic area neurons expressing melanin-concentrating hormone during lactation. J Chem Neuroanat 39: 51-62.
55. Saper CB, Swanson LW, Cowan WM. 1976. The efferent connections of the ventromedial nucleus of the hypothalamus of the rat. J Comp Neurol 169: 409-442.
56. Shimizu N, Oomura Y, Plata-Salaman CR, Morimoto M. 1987. Hyperphagia and obesity in rats with bilateral ibotenic acid-induced lesions of the ventromedial hypothalamic nucleus. Brain Res 416: 153-156.
57. Suarez J, Romero-Zerbo SY, Rivera P, Bermudez-Silva FJ, Perez J, De Fonseca FR, Fernandez-Llebrez P. 2010. Endocannabinoid system in the adult rat circumventricular areas: an immunohistochemical study. J Comp Neurol 518: 3065-3085.
58. Swanson LW, Mogenson GJ. 1981. Neural mechanisms for the functional coupling of autonomic, endocrine and somatomotor responses in adaptive behavior. Brain Res 228: 1-34.
59. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
60. Vann SD, Aggleton JP. 2004. The mammillary bodies: two memory systems in one? Nat Rev Neurosci 5: 35-44.
61. Varga V, Hangya B, Kranitz K, Ludanyi A, Zemankovics R, Katona I, Shigemoto R, Freund TF, Borhegyi Z. 2008. The presence of pacemaker HCN channels identifies theta rhythmic GABAergic neurons in the medial septum. J Physiol 586: 3893-3915.
62. Vizi ES, Katona I, Freund TF. 2001. Evidence for presynaptic cannabinoid CB(1) receptor-mediated inhibition of noradrenaline release in the guinea pig lung. Eur J Pharmacol 431: 237-244.
63. Wittmann G, Deli L, Kallo I, Hrabovszky E, Watanabe M, Liposits Z, Fekete C. 2007. Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus. J Comp Neurol 503: 270-279.